| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/21/1998 | US5741792 Anticoagulants of sulfonamido heterocyclic thrombin inhibitors |
| 04/21/1998 | US5741781 Mercaptoalkanoyldipeptide compounds |
| 04/21/1998 | US5741779 Slowing clot formation in blood by administering bactericidal/permeability-increasing protein product |
| 04/21/1998 | US5741778 Preventing neuronal cell death |
| 04/21/1998 | US5741777 Modulation of wound contraction by blocking protein tyrosine phosphatase |
| 04/21/1998 | US5741776 Method of administration of IGF-I |
| 04/21/1998 | US5741775 Antibiotic and antifungal agents |
| 04/21/1998 | US5741774 Use of a cytokine regulatory agent to treat rheumatoid arthritis |
| 04/21/1998 | US5741773 Storage stable dentifrice composition containing an antibacterial casein glycomacropeptide adjuvant |
| 04/21/1998 | US5741772 Polypeptide |
| 04/21/1998 | US5741771 Plasminogen activator and thrombin-activatable plasminogen analogue |
| 04/21/1998 | US5741706 Anti-HIV ribozymes |
| 04/21/1998 | US5741692 Used in compositions for selectively and completely disinserting vitreous body from neural retina of an eye |
| 04/21/1998 | US5741689 Methods to inhibit serine kinase activity and to alter intersubunit binding activity of phosphatidylinositol 3-kinase, and serine kinase active sequence of the same |
| 04/21/1998 | US5741679 Regulatable nucleic acid therapeutic and methods of use thereof |
| 04/21/1998 | US5741673 Nucleic acid encoding a novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 04/21/1998 | US5741670 Polypeptides |
| 04/21/1998 | US5741666 Compositions and methods, for the treatment of body weight disorders, including obesity |
| 04/21/1998 | US5741656 Epstein-Barr virus sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests |
| 04/21/1998 | US5741651 Drug screening |
| 04/21/1998 | US5741642 Assay for detecting the expression of a gene encoding human keratinocyte growth factor (KGF) |
| 04/21/1998 | US5741641 Cell culture; incubation; analyzing |
| 04/21/1998 | US5741514 Intravenously injecting small unilammellar lipopsomes of phosphatidylcholines |
| 04/21/1998 | US5741512 Pharmaceutical compositions comprising cyclosporins |
| 04/21/1998 | US5741492 Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses |
| 04/21/1998 | US5741490 Immunogenic composition comprising peptide containing carboxy-terminal amino acids of capsid protein encoded by second open reading frame of hepatitis e virus genome, carrier |
| 04/21/1998 | US5741488 Treatment of rheumatoid arthritis with anti-CD4 antibodies in conjunction with anti-TNF antibodies |
| 04/21/1998 | US5741487 Mutanase-containing oral compositions |
| 04/21/1998 | US5741486 Safe vectors for gene therapy |
| 04/21/1998 | US5741485 Crystalline complexes has monoclinic morphology and x-ray diffraction |
| 04/21/1998 | US5741484 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/21/1998 | CA1339830C Human monoclonal antibody to lymphadenopathy associated virus |
| 04/21/1998 | CA1339829C Produit of interferon from human genes |
| 04/16/1998 | WO1998015658A1 Compositions and methods for treating viral infections |
| 04/16/1998 | WO1998015647A1 Modulation of apoptosis |
| 04/16/1998 | WO1998015643A1 Fragments of plasminogen effective in inhibiting tumor metastasis and growth and process for preparing the same |
| 04/16/1998 | WO1998015635A2 Treatment of cancer using a recombinant poxvirus containing a nucleic acid sequence encoding a cytokine |
| 04/16/1998 | WO1998015632A1 A human protein tyrosine kinase |
| 04/16/1998 | WO1998015629A1 Binding proteins for phosphoinositides, grp1 or general receptor 1 for phosphoinositide |
| 04/16/1998 | WO1998015628A1 Novel semaphorin gene: semaphorin w |
| 04/16/1998 | WO1998015626A2 Mutant ciita molecule and uses thereof |
| 04/16/1998 | WO1998015624A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | WO1998015623A1 Hypertension markers |
| 04/16/1998 | WO1998015618A1 Map kinases: polypeptides, polynucleotides and uses thereof |
| 04/16/1998 | WO1998015616A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | WO1998015615A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | WO1998015578A1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| 04/16/1998 | WO1998015577A1 METHODS OF ACTIVATING OR ENHANCING Fc RECEPTORS |
| 04/16/1998 | WO1998015576A1 Platelet secretory transport protein |
| 04/16/1998 | WO1998015575A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | WO1998015574A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | WO1998015573A1 20-o-linked camptothecin glycoconjugates |
| 04/16/1998 | WO1998015571A1 Modified cytostatic agents |
| 04/16/1998 | WO1998015570A1 Dna encoding galanin galr3 receptors and uses thereof |
| 04/16/1998 | WO1998015569A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection |
| 04/16/1998 | WO1998015535A1 1,4-benzodiazepinones and their uses as cck antagonists |
| 04/16/1998 | WO1998015292A1 Viscous hemostatic composition, in particular in gel state |
| 04/16/1998 | WO1998015285A1 Methods and compositions for inducing a protective immune response to cancers |
| 04/16/1998 | WO1998015283A1 Agents for the regulation of oestrogen synthesis |
| 04/16/1998 | WO1998015282A1 Immunogenic tlp composition |
| 04/16/1998 | WO1998015179A1 Therapeutic and diagnostic applications of laminin and laminin-derived protein fragments |
| 04/16/1998 | WO1998011232A3 Human nm23-like protein |
| 04/16/1998 | WO1998011211A3 Method for using oligonucleotides having modified cpg dinucleosides |
| 04/16/1998 | WO1998007876A3 Self-replicating episomal expression vectors conferring tissue-specific gene expression |
| 04/16/1998 | DE19641466A1 Orale Anwendung eines Immunglobulinpräparates zur Prävention des Hämolytischen Urämischen Syndroms sowie Präparat hierfür Oral administration of an immunoglobulin preparation for the prevention of hemolytic uremic syndrome and preparation thereof |
| 04/16/1998 | DE19641213A1 Cyclic peptide(s) from Bacillus amyloliquefaciens |
| 04/16/1998 | DE19640970A1 Modifizierte Cytostatika Modified cytostatics |
| 04/16/1998 | DE19640969A1 20-0-verknüpfte Glycokonjugate von Camptothecin 20-0-linked glycoconjugates of camptothecin |
| 04/16/1998 | CA2269090A1 Methods for generating cytotoxic t cells in vitro |
| 04/16/1998 | CA2268284A1 Method of producing a thymic microenvironment that supports the development of dendritic cells |
| 04/16/1998 | CA2268022A1 Galectin 8, 9, 10 and 10sv |
| 04/16/1998 | CA2268006A1 Novel semaphorin gene: semaphorin w |
| 04/16/1998 | CA2267905A1 Immunogenic tlp composition |
| 04/16/1998 | CA2267662A1 Gp120 polypeptides having conformational discontinuous chemokine receptor binding sites and methods of inhibiting hiv infection |
| 04/16/1998 | CA2267656A1 Map kinases: polypeptides, polynucleotides and uses thereof |
| 04/16/1998 | CA2267646A1 Platelet secretory transport protein |
| 04/16/1998 | CA2267637A1 Hypertension markers |
| 04/16/1998 | CA2267067A1 Promoter for smooth muscle cell expression |
| 04/16/1998 | CA2266424A1 A human protein tyrosine kinase |
| 04/16/1998 | CA2265550A1 Methods and compositions for generating angiostatin |
| 04/16/1998 | CA2248222A1 Dna encoding galanin galr3 receptors and uses thereof |
| 04/15/1998 | EP0835939A2 Fusion proteins with parts of immunoglobulins, their production and use |
| 04/15/1998 | EP0835938A2 Topoisomerase I |
| 04/15/1998 | EP0835937A2 Human MYT-1 kinase clone |
| 04/15/1998 | EP0835936A2 Arginyl tRNA synthase |
| 04/15/1998 | EP0835933A2 A G-protein coupled receptor, HLTEX11 |
| 04/15/1998 | EP0835932A1 Non- glycosylated FGF-4 and compositions containing the same |
| 04/15/1998 | EP0835880A1 Process for producing an IgM preparation for intravenous administration |
| 04/15/1998 | EP0835879A2 Analogs of obesity proteins and pharmaceutical formulations comprising them |
| 04/15/1998 | EP0835662A2 A drug for the treatment of cancer |
| 04/15/1998 | EP0835661A2 Human interferon-Beta2A for use as a medicament |
| 04/15/1998 | EP0835447A1 Novel peptides and compositions which modulate apoptosis |
| 04/15/1998 | EP0835326A1 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
| 04/15/1998 | EP0835319A1 INTERACTION OF p53 WITH TRANSCRIPTION FACTOR DP-1 |
| 04/15/1998 | EP0835315A1 Vaccine for porcine reproductive and respiratory syndrome virus |
| 04/15/1998 | EP0835314A1 Immunogenic detoxified mutant of cholera toxins |
| 04/15/1998 | EP0835312A2 Recombinant mistletoe lectin |
| 04/15/1998 | EP0835308A1 Bax omega protein and methods |
| 04/15/1998 | EP0835306A1 Recombinant antibodies from a phage display library, directed against a peptide-mhc complex |
| 04/15/1998 | EP0835305A1 Cytokine that induces apoptosis |